(Q46495151)

22 December 2017

title

Optimisation of a mycobacterial replicon increases foreign antigen expression in mycobacteria (English)

1 reference

22 December 2017

Anna-Lise Williamson

2

0 references

author name string

Sarah Griffin

series ordinal

1

1 reference

22 December 2017

Rosamund Chapman

series ordinal

3

1 reference

22 December 2017

publication date

6 May 2009

1 reference

22 December 2017

published in

Tuberculosis

1 reference

22 December 2017

volume

89

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

225-232

1 reference

22 December 2017

A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guérin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Complete nucleotide sequence of pAL5000, a plasmid from Mycobacterium fortuitum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Functional definition of regions necessary for replication and incompatibility in the Mycobacterium fortuitum plasmid pAL5000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Functional analysis of pAL5000 plasmid in Mycobacterium fortuitum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Identification of promoter elements in mycobacteria: mutational analysis of a highly symmetric dual promoter directing the expression of replication genes of the Mycobacterium plasmid pAL5000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Protein-DNA interactions in the ori region of the Mycobacterium fortuitum plasmid pAL5000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Origin binding activity of the Mycobacterial plasmid pAL5000 replication protein RepB is stimulated through interactions with host factors and coupled expression of repA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Translational coupling to an upstream gene promotes folding of the mycobacterial plasmid pAL5000 replication protein RepB and thereby its origin binding activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Functional analysis of pAL5000, a plasmid from Mycobacterium fortuitum: construction of a "mini" mycobacterium-Escherichia coli shuttle vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Immune responses induced by recombinant BCG strains according to level of production of a foreign antigen: MalE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Creation and characterisation of a high-copy-number version of the pAL5000 mycobacterial replicon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Genetic alteration of Mycobacterium smegmatis to improve mycobacterium-mediated transfer of plasmid DNA into mammalian cells and DNA immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Electroporation of mycobacteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

New use of BCG for recombinant vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette-Guérin expressing human immunodeficiency virus type 1 Gag.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Plasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Comparative evaluation of Mycobacterium vaccae as a surrogate cloning host for use in the study of mycobacterial genetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Structural instability of recombinant plasmids in mycobacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Stable integration and expression of the Plasmodium falciparum circumsporozoite protein coding sequence in mycobacteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Differential gene expression between Mycobacterium bovis and Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Molecular characterization of the eis promoter of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Genetic rearrangements leading to disruption of heterologous gene expression in mycobacteria: an observation with Escherichia coli beta-galactosidase in Mycobacterium smegmatis and its implication in vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Expression of foreign genes in Mycobacterium bovis BCG strains using different promoters reveals instability of the hsp60 promoter for expression of foreign genes in Mycobacterium bovis BCG strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

Silencing Mycobacterium smegmatis by using tetracycline repressors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2009.03.006

10.1016/J.TUBE.2009.03.006

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017